The Quotes are Powered By Forexpros, the Forex, Futures, and Stock Markets Portal.

AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion

Thursday, 19 December 2013
The Swedish – British pharmaceutical firm, AstraZeneca has agreed to buy Bristol-Myers Squibb’s stake in the companies’ diabetes joint venture for up to $4.1 billion in a deal that will help return the group to growth, sending its shares to a new high. drugs

According to reports from Reuters, AstraZeneca said on Thursday that it would pay Bristol an initial $2.7 billion plus up to $1.4 billion in additional regulatory and sales-related payments.
Detail and more reports from Reuters

Did you spot any error(s) or had any problem with the above article. Please contact us